27
Cambrian BioPharma Inc files Form D
Company raise update · Raising · Offering $37.6M · Sold $23M · NEW YORK, NY · filed 2025-01-13
55
Cambrian BioPharma Inc raises $123.8M under Reg D
Company raise · Raising · NEW YORK, NY · Form D filed 2026-07-15
$50M+ raiseBusiness combination
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| James Peyer | Executive Officer, Director |
| Mark Nuttall | Executive Officer |
| Christian Angermeyer | Director |
| Brenton L. Saunders | Director |
| Martin L. Gunhaga | Director |
| Juliette Han | Executive Officer, Director |
| Maryanna Saenko | Director |
| Ruth Thieroff-Ekerdt | Executive Officer |
| William DeVaul | Executive Officer |
| Lorin L. Van Nuland | Director |
| Paul L. Farr | Director |
Signed by William DeVaul, Chief Legal Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.